Preclinical studies in animal models have yielded several noteworthy findings
A typical bacteriostatic water vial contains 30ml, enough for multiple reconstitutions
FDA's career scientists have made clear they don't think there's enough data to support making peptides more widely available, specifically from compounding pharmacies, which mix customized medicines that aren't available from traditional drugmakers
Management typically involves estrogen monitoring through blood tests and, when necessary, aromatase inhibitors or selective estrogen receptor modulators
[12] Healthcare providers will monitor any unusual responses and can adjust treatment if any potential interaction is suspected
There is insufficient data to show complete safety for use in pregnant people, but its used when the benefits outweigh the potential risks